Covington advised Insmed Incorporated on the deal while Fenwick represented Pharmakon. Walder Wyss advised the funds managed by Pharmakon Advisors, LP, BioPharma Credit and OrbiMed. Akin...
Insmed Incorporated’s $775 Million Financing
NewAmsterdam Pharma’s DeSPAC Merger with Frazier Lifesciences
Covington and NautaDutilh advised NewAmsterdam Pharma on the deal, while Latham & Watkins advised Lincoln International. Houthoff assisted Frazier Lifesciences Acquisition Corp. NewAmsterdam Pharma Holding B.V.,...
UCB’s Acquisition of Zogenix
Covington represented UCB, while Latham & Watkins represented Zogenix on the deal. Fried Frank acted as counsel to BofA Securities and SVB Leerink as financial advisors to...
EMX Capital’s GP-Led Secondary Restructuring
Covington & Burling and Ritch, Mueller y Nicolau advised EMX Capital on the deal. Private equity fund EMX Capital announced the successful completion of an innovative general...
DuPont’s $5.2 Billion Acquisition of Rogers Corporation
Skadden, Arps, Slate, Meagher & Flom advised DuPont on the deal while Covington & Burling represented Rogers Corporation. Fried Frank acted as counsel to Evercore as...
SoftBank Latin America Fund’s US$150 Million Investment in Grupo Bursátil Mexicano
Morrison & Foerster and Mijares, Angoitia, Cortés y Fuentes advised SoftBank Latin America Fund on the deal. Covington & Burling and Graham Abogados advised Corporativo GBM,...